Acadia Pharmaceuticals (ACAD) Interest & Investment Income (2010 - 2026)
Acadia Pharmaceuticals (ACAD) posted Interest & Investment Income of $8.0 million for Q2 2026, down 0.81% on a QoQ basis from $8.1 million in Q1 2026, and up 10.31% year-over-year from $7.2 million in Q2 2025.
Powered by 
Analysis
Acadia Pharmaceuticals (ACAD) Interest & Investment Income (2010 - 2026) Analysis & Trends
Acadia Pharmaceuticals has reported Interest & Investment Income for 17 years, with the latest figure at $8.0 million in Q2 2026.
- On a quarterly basis, Interest & Investment Income rose 10.31% year-over-year to $8.0 million in Q2 2026; TTM through Jun 2026 was $32.6 million, a 13.52% increase from a year earlier, with the FY2025 full-year figure at $31.7 million, up 24.61% from the prior year.
- Interest & Investment Income was $8.0 million for Q2 2026 at Acadia Pharmaceuticals, down from $8.1 million in the prior quarter.
- The five-year high for Interest & Investment Income was $8.3 million in Q4 2025, with the low at $105000.0 in Q1 2022.
- Average Interest & Investment Income over 5 years is $5.4 million, with a median of $5.9 million recorded in 2024.
- The sharpest annual moves came in 2022 and 2023: Interest & Investment Income sank 47.5% in 2022, then soared 3519.05% in 2023.
- Over 5 years, Interest & Investment Income stood at $3.6 million in 2022, then surged by 31.1% to $4.8 million in 2023, then surged by 47.24% to $7.0 million in 2024, then climbed by 18.91% to $8.3 million in 2025, then declined by 4.1% to $8.0 million in 2026.
- The last three Interest & Investment Income figures came in at $8.0 million (Q2 2026), $8.1 million (Q1 2026), and $8.3 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | 219.00 Mn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | -679.00 Mn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | 80.00 Mn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | - |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | 120.60 Mn |
| 10 | Acadia Pharmaceuticals | 4.38 Bn | 3.42 Bn | 279.64 Mn | 7.99 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.99 Mn |
| Mar 31, 2026 | 8.06 Mn |
| Dec 31, 2025 | 8.33 Mn |
| Sep 30, 2025 | 8.25 Mn |
| Jun 30, 2025 | 7.24 Mn |
| Mar 31, 2025 | 7.90 Mn |
| Dec 31, 2024 | 7.01 Mn |
| Sep 30, 2024 | 6.59 Mn |
| Jun 30, 2024 | 6.36 Mn |
| Mar 31, 2024 | 5.51 Mn |
| Dec 31, 2023 | 4.76 Mn |
| Sep 30, 2023 | 4.13 Mn |
| Jun 30, 2023 | 4.55 Mn |
| Mar 31, 2023 | 3.80 Mn |
| Dec 31, 2022 | 3.63 Mn |
| Sep 30, 2022 | 2.30 Mn |
| Jun 30, 2022 | 580,000.00 |
| Mar 31, 2022 | 105,000.00 |
| Dec 31, 2021 | 129,000.00 |
| Sep 30, 2021 | 129,000.00 |
API Access
Acadia Pharmaceuticals Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ACAD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "ACAD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ACAD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();